170 related articles for article (PubMed ID: 11710597)
1. P53 mutation and response to hepatic arterial floxuridine in patients with colorectal liver metastases.
Khan ZA; Jonas SK; Feldmann KA; Patel H; Wharton RQ; Tarragona A; Ivison A; Allen-Mersh TG
J Cancer Res Clin Oncol; 2001 Nov; 127(11):675-80. PubMed ID: 11710597
[TBL] [Abstract][Full Text] [Related]
2. Colorectal liver metastasis thymidylate synthase staining correlates with response to hepatic arterial floxuridine.
Davies MM; Johnston PG; Kaur S; Allen-Mersh TG
Clin Cancer Res; 1999 Feb; 5(2):325-8. PubMed ID: 10037181
[TBL] [Abstract][Full Text] [Related]
3. p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas.
Benhattar J; Cerottini JP; Saraga E; Metthez G; Givel JC
Int J Cancer; 1996 Jun; 69(3):190-2. PubMed ID: 8682586
[TBL] [Abstract][Full Text] [Related]
4. Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver.
van Riel JM; van Groeningen CJ; Giaccone G; Pinedo HM
Oncology; 2000 Aug; 59(2):89-97. PubMed ID: 10971164
[TBL] [Abstract][Full Text] [Related]
5. Determination of microsatellite instability, p53 and K-RAS mutations in hepatic metastases from patients with colorectal cancer: relationship with response to 5-fluorouracil and survival.
Rosty C; Chazal M; Etienne MC; Letoublon C; Bourgeon A; Delpero JR; Pezet D; Beaune P; Laurent-Puig P; Milano G
Int J Cancer; 2001 May; 95(3):162-7. PubMed ID: 11307149
[TBL] [Abstract][Full Text] [Related]
6. Characterization of p53 mutations in colorectal liver metastases and correlation with clinical parameters.
Tullo A; D'Erchia AM; Honda K; Mitry RR; Kelly MD; Habib NA; Saccone C; Sbisà E
Clin Cancer Res; 1999 Nov; 5(11):3523-8. PubMed ID: 10589767
[TBL] [Abstract][Full Text] [Related]
7. P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection.
Yang Y; Forslund A; Remotti H; Lönnroth C; Andersson M; Brevinge H; Svanberg E; Lindnér P; Hafström L; Naredi P; Lundholm K
Cancer; 2001 Feb; 91(4):727-36. PubMed ID: 11241240
[TBL] [Abstract][Full Text] [Related]
8. A role for hepatic-directed chemotherapy in colorectal liver metastases.
Ensminger WD
J Clin Oncol; 2005 Aug; 23(22):4815-7. PubMed ID: 16009957
[No Abstract] [Full Text] [Related]
9. Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer.
Kemeny N; Cohen A; Seiter K; Conti JA; Sigurdson ER; Tao Y; Niedzwiecki D; Botet J; Budd A
J Clin Oncol; 1993 Feb; 11(2):330-5. PubMed ID: 8426211
[TBL] [Abstract][Full Text] [Related]
10. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update.
Kemeny N; Seiter K; Conti JA; Cohen A; Bertino JR; Sigurdson ER; Botet J; Chapman D; Mazumdar M; Budd AJ
Cancer; 1994 Feb; 73(4):1134-42. PubMed ID: 8313315
[TBL] [Abstract][Full Text] [Related]
11. Association of p53 mutations, microvessel density and neoangiogenesis in pairs of colorectal cancers and corresponding liver metastases.
Kern A; Taubert H; Scheele J; Rudroff C; Mothes H; Kappler M; Bartel F; Richter KK
Int J Oncol; 2002 Aug; 21(2):243-9. PubMed ID: 12118317
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.
Ben-Josef E; Normolle D; Ensminger WD; Walker S; Tatro D; Ten Haken RK; Knol J; Dawson LA; Pan C; Lawrence TS
J Clin Oncol; 2005 Dec; 23(34):8739-47. PubMed ID: 16314634
[TBL] [Abstract][Full Text] [Related]
13. Hepatic artery infusion for liver metastases from colorectal cancer.
Bonetti A
Lancet; 2003 Feb; 361(9355):358-9. PubMed ID: 12573366
[No Abstract] [Full Text] [Related]
14. Systemic irinotecan or regional floxuridine chemotherapy prolongs survival after hepatic cryosurgery in patients with metastatic colon cancer refractory to 5-fluorouracil.
Bilchik AJ; Wood TF; Chawla SP; Rose DM; Chung MH; Stern SS; Foshag LJ; Ramming KP
Clin Colorectal Cancer; 2001 May; 1(1):36-42. PubMed ID: 12445377
[TBL] [Abstract][Full Text] [Related]
15. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.
Allen-Mersh TG; Earlam S; Fordy C; Abrams K; Houghton J
Lancet; 1994 Nov; 344(8932):1255-60. PubMed ID: 7526096
[TBL] [Abstract][Full Text] [Related]
16. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.
Kemeny N; Huang Y; Cohen AM; Shi W; Conti JA; Brennan MF; Bertino JR; Turnbull AD; Sullivan D; Stockman J; Blumgart LH; Fong Y
N Engl J Med; 1999 Dec; 341(27):2039-48. PubMed ID: 10615075
[TBL] [Abstract][Full Text] [Related]
17. Phase II evaluation of treatment of complete resection of hepatic metastases from colorectal cancer and adjuvant hepatic arterial infusion of floxuridine: an Eastern Cooperative Oncology Group Study (PB083).
Berlin J; Merrick HW; Smith TJ; Lerner H
Am J Clin Oncol; 1999 Jun; 22(3):291-3. PubMed ID: 10362339
[TBL] [Abstract][Full Text] [Related]
18. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study.
Kemeny MM; Adak S; Gray B; Macdonald JS; Smith T; Lipsitz S; Sigurdson ER; O'Dwyer PJ; Benson AB
J Clin Oncol; 2002 Mar; 20(6):1499-505. PubMed ID: 11896097
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases.
Sturm I; Köhne CH; Wolff G; Petrowsky H; Hillebrand T; Hauptmann S; Lorenz M; Dörken B; Daniel PT
J Clin Oncol; 1999 May; 17(5):1364-74. PubMed ID: 10334520
[TBL] [Abstract][Full Text] [Related]
20. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer.
Gray B; Van Hazel G; Hope M; Burton M; Moroz P; Anderson J; Gebski V
Ann Oncol; 2001 Dec; 12(12):1711-20. PubMed ID: 11843249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
